• ABOUT US
    • Royal Canin Academy Digital Library
    • Royal Canin Academy learning platform
    • Royal Canin Campus tour
    • Royal Canin Foundation
    • Royal Canin Career

  • Contact Us
image/svg+xml
HomeVeterinaryAssociations between echocardiography, cardiac biomarkers, insulin metabolism, morphology and inflammation in feline asymptomatic hypertrophic cardiomyopathy

Associations between echocardiography, cardiac biomarkers, insulin metabolism, morphology and inflammation in feline asymptomatic hypertrophic cardiomyopathy

Authors: Ingrid van Hoek , Hannah Hodgkiss-Geere , Elizabeth F. Bode , Julie Hamilton-Elliott , Paul Mõtsküla, Valentina Palermo , Yolanda M. Pereira , Geoff J. Culshaw , Anna Ivanova , Jo Dukes-McEwan

Journal of Veterinary Internal Medicine, Volume 34, March 2020

doi.org/10.1111/jvim.15730

Share on social media

    • VETERINARY TEAMS
    • VET FOCUS
      • Royal Canin Academy Digital Library
      • Royal Canin Academy learning platform
      • Royal Canin Campus tour
      • Royal Canin Foundation

      • Royal Canin Career
      topnav dogs on couch
    • Any Questions?

      Need help? Visit our Contact Us page or reach us directly.

      • By Email
      • About us
    Reading time5 - 15 min

    Abstract

    Background

    Insulin, insulin-like growth factor-1 (IGF-1), and inflammation possibly are involved in cats with asymptomatic hypertrophic cardiomyopathy (aHCM).

    Objectives

    To evaluate echocardiography, morphology, cardiac and inflammatory markers, insulin and IGF-1 in cats with aHCM.

    Animals

    Fifty-one client-owned cats with aHCM.

    Methods

    Observational descriptive study. Variables (body weight [BW], body condition score [BCS], echocardiography, and serum concentrations of N-terminal pro-B-type natriuretic peptide [NT-proBNP], ultra-sensitive troponin-I [c-TnI], serum amyloid A [SAA], insulin, glucose and IGF-1) were evaluated for significant increases above echocardiography cutoff values and laboratory reference ranges, associations and effect of left atrial (LA) remodeling and generalized hypertrophy.

    Results

    Cats with aHCM had BCS ≥6/9 (P = .01) and insulin (P < .001), NT-proBNP (P = .001) and cTn-I (P < .001) above laboratory reference ranges. Associations were present between NT-proBNP and maximum end-diastolic interventricular septum thickness (IVSd; ρ = .32; P = .05), maximum end-diastolic left ventricular free wall thickness;(ρ = .41; P = .01), LA/Aorta (ρ = .52; P = .001) and LA diameter (LA-max; ρ = .32; P = .05); c-TnI and LA/Aorta (ρ = .49; P = .003) and LA-max (ρ = .28; P = .05); and SAA and number of IVSd regions ≥6 mm thickness (ρ = .28; P = .05). Body weight and BCS were associated with IGF-1 (r = 0.44; P = .001), and insulin (ρ = .33; P = .02), glucose (ρ = .29; P = .04) and IGF-1 (ρ = .32; P = .02), respectively. Concentrations of NT-proBNP (P = .02) and c-TnI (P = .01), and SAA (P = .02), were higher in cats with LA remodeling, and generalized hypertrophy, respectively.

    Conclusion and Clinical Importance

    Results suggest potential implications of insulin, IGF-1, and inflammation in cats with aHCM, but it remains to be confirmed whether these findings represent a physiological process or a part of the pathogenesis and development of disease

     

    Access the article